Literature DB >> 20813788

Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow-up study.

Hanna Pelttari1, Matti J Välimäki, Eliisa Löyttyniemi, Camilla Schalin-Jäntti.   

Abstract

OBJECTIVE: To study whether post-surgical and/or post-ablative thyroglobulin (Tg) concentrations may serve as independent predictors of disease recurrence in patients treated for TNM stage I or II well-differentiated thyroid carcinoma (WDTC).
DESIGN: An observational retrospective study with a median follow-up of 16 years (range 10-24). PATIENTS AND MEASUREMENTS: Post-operative and post-ablative Tg concentrations, age, tumour size, local infiltration and nodal metastasis at primary surgery as well as disease recurrences and cancer-specific deaths were evaluated in 495 low-risk (TNM stages I and II) patients, the majority of whom had total thyroidectomy and radioactive iodine remnant ablation as initial treatment.
RESULTS: Fifty-one patients (10.3%) experienced disease recurrence during follow-up. In multiple logistic regression analysis, post-ablative Tg concentrations (odds ratio (OR) 3.72, confidence interval (CI) 1.71-8.05, P=0.0009) and local infiltration on primary surgery (OR 2.66, CI 1.03-6.90, P=0.04) were the only independent predictors of recurrence.
CONCLUSIONS: Post-ablative Tg concentration is a strong predictor of disease recurrence in WDTC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813788     DOI: 10.1530/EJE-10-0553

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  9 in total

Review 1.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

2.  Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level.

Authors:  Heribert Hänscheid; Frederik Anton Verburg; Johannes Biko; Stefanie Diessl; Yuri E Demidchik; Valentina Drozd; Christoph Reiners
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-02       Impact factor: 9.236

3.  The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.

Authors:  Mehmet Hakan Korkmaz; Bülent Öcal; Güleser Saylam; Erman Çakal; Ömer Bayır; Esra Tutal; Emel Çadallı Tatar
Journal:  Langenbecks Arch Surg       Date:  2017-02-21       Impact factor: 3.445

4.  Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies.

Authors:  Mark M Kushnir; Alan L Rockwood; William L Roberts; Dev Abraham; Andrew N Hoofnagle; A Wayne Meikle
Journal:  Clin Chem       Date:  2013-02-08       Impact factor: 8.327

Review 5.  Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review.

Authors:  Eleonora Farina; Fabio Monari; Giovanni Tallini; Andrea Repaci; Renzo Mazzarotto; Francesca Giunchi; Riccardo Panzacchi; Silvia Cammelli; Gilbert D A Padula; Francesco Deodato; Renato Pasquali; Stefano Fanti; Michelangelo Fiorentino; Alessio G Morganti
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

6.  Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer.

Authors:  Chang-Hee Lee; Ji-Hoon Jung; Seung Hyun Son; Chae Moon Hong; Ju Hye Jeong; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  PLoS One       Date:  2018-08-17       Impact factor: 3.240

7.  Role of Preablative Stimulated Thyroglobulin in Prediction of Nodal and Distant Metastasis on Iodine Whole-Body Scan.

Authors:  Meghana Prabhu; Sanju Samson; Avinash Reddy; Sunil Hejaji Venkataramanarao; Naveen Hedne Chandrasekhar; Vijay Pillai; Vivek Shetty; Moni Abraham Koriokose; Bushan Vaidhya; Subramanian Kannan
Journal:  Indian J Nucl Med       Date:  2018 Apr-Jun

8.  Low-Dose Radioiodine Ablation in Patients with Low-Risk Differentiated Thyroid Cancer.

Authors:  Germán A Jimenez Londoño; Ana Maria Garcia Vicente; Julia Sastre Marcos; Francisco Jose Pena Pardo; Mariano Amo-Salas; Manuel Moreno Caballero; Maria Prado Talavera Rubio; Beatriz Gonzalez Garcia; Niletys Dafne Disotuar Ruiz; Angel Maria Soriano Castrejón
Journal:  Eur Thyroid J       Date:  2018-07-05

9.  Optimization of serum thyroglobulin measured at different time points for prognostic evaluation in differentiated thyroid carcinoma patients.

Authors:  Pupree Mutsuddy; Subin Jeon; Su Woong Yoo; Yingjie Zhang; Md Sunny Anam Chowdhury; Jahae Kim; Ho-Chun Song; Hee-Seung Bom; Jung-Joon Min; Seong Young Kwon
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.